New hope for early breast cancer: smarter drug combinations tested
NCT ID NCT06535893
First seen Nov 20, 2025 · Last updated May 22, 2026 · Updated 25 times
Summary
This study tests new drug combinations for people with early-stage breast cancer (stage II or III) who need chemotherapy before surgery. The goal is to see if these new treatments can eliminate all cancer cells in the breast and lymph nodes better than standard therapy. About 100 adults aged 18 to 80 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nagoya City University
RECRUITINGNagoya, Aichi-ken, 467-8601, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.